课题基金 / 基金详情

CHECKPOINT FOR B CELL SURVIVAL IN HUMAN GUT

CHECKPOINT FOR B CELL SURVIVAL IN HUMAN GUT
人类肠道中 B 细胞存活的检查点
批准号:
MR/P021964/1
负责人:
Jo Spencer
金额:
$54.71万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

Jo Spencer的其他基金

相似基金

相关文献

中文摘要
翻译
B细胞是免疫系统的细胞。B细胞通过识别B细胞表面称为B细胞受体的非常特定的受体来识别感染颗粒,从而对抗感染。B细胞受体通过它们的个体形状识别感染性病原体,并以一种锁和钥匙的方式与它们结合。数以百万计的B细胞在血液和身体组织中循环,每个B细胞都有该B细胞独有的B细胞受体。因此,无论什么感染源进入人体,都会有一个B细胞与一个互补形状的受体结合在一起。如果B细胞通过其B细胞受体与感染颗粒结合,B细胞可能被激活并分泌其B细胞受体,该B细胞受体将结合并对抗感染性病原体。当B细胞受体被分泌时,它被称为抗体。产生具有独特受体的庞大而多样的B细胞集的过程有一个主要的相关危险。B细胞可以与人体自身的细胞和组织结合,并能够攻击它们。免疫系统的其他细胞称为T细胞,具有调节B细胞的能力,它们本身也能很好地区分自体和异体。然而,许多B细胞可以产生T细胞非依赖的反应,如果没有适当的特定调控,这些反应是特别危险的。以T细胞非依赖的方式激活B细胞的感染因子包括那些引起某些类型肺炎的病原体。B细胞有一个额外的技巧来识别这些病原体,因为它们的表面有重复的形状图案。B细胞可能能够通过B细胞受体识别形状,也可以识别形状呈现的规律性。我们实验室的实验表明,B细胞选择将防止自我反应,并促进对激活B细胞的颗粒的反应性,而不是T细胞,这种选择发生在肠道中。肠道中含有许多“友好的”细菌,这些细菌不断刺激肠道所含的免疫系统。我们的实验表明,这种环境支持B细胞发育的各个阶段,而人类B细胞免疫学模型或人类疾病评估在很大程度上忽略了这些阶段。我们称这为‘检查点’,因为这是B细胞发育的一个阶段,只有具有所需特性的细胞才被允许通过。在许多物种中,肠道以不同的方式参与B细胞的发育,包括鸡、小鼠、绵羊和兔子。因此,肠道对人类B细胞发育的影响是重要的,也很有可能发生,但仍是完全神秘的。本申请中描述的实验的目的是了解B细胞如何在肠道中成熟,以及这是如何调节的。
英文摘要
B cells are cells of the immune system. B cells fight infections by identifying infectious particles via very specific receptors on the B cell surface, called the B cell receptors. B cell receptors recognise infectious agents by their individual shape and they bind to them in a lock-and-key way. Millions of B cells circulate through the blood and tissues of the body and each B cell has a B cell receptor that is unique to that B cell. As a consequence, no matter what infectious agent finds its way into the body, there will be a B cell with a receptor of the complementary shape to bind it. If a B cell binds to an infectious particle via its B cell receptor, the B cell may become activated and secrete its B cell receptor that will bind to and fight the infectious agent. When the B cell receptor is secreted it is referred to as antibody.The process that generates the huge and diverse set of B cells with unique receptors has a major associated hazard. B cells can be produced that bind to the body's own cells and tissues and can attack them. Other cells of the immune system called T cells have the capacity to regulate B cells and they themselves can discriminate well between self and non-self. However, many B cells can make T cell independent responses and these are particularly dangerous if not properly regulated for specificity.The infectious agents that activate B cells in a T-cell independent way include those that cause some types of pneumonia. B cells have an additional trick to recognise these agents because they have a repeating pattern of shapes on the surface. B cells may be able to recognise the shape through the B cell receptor, but also the regularity with which the shape is presented. Experiments in our lab suggest that B cell selection that would prevent self-reactivity and promote responsiveness to particles that activate B cells independent of T cells happens in the gut. The gut contains a lot of 'friendly' bacteria that constantly stimulate the immune system it contains. Our experiments suggest that this environment supports stages in B cell development that are largely ignored in models of human B cell immunology or assessment of human disease. We call this a 'checkpoint' because it is a stage of B cell development where only cells that have a required set of properties are allowed to pass. The gut is involved in the development of B cells in different ways in many species, including chickens, mice, sheep and rabbits. Therefore an influence of the gut on human B cell development is important and highly likely to occur, but as yet totally mysterious.The aims of experiments described in this application are to understand how B cells mature in the gut and how this is regulated.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41467-018-06089-1
发表时间: 2018-09-21
期刊: Nature communications
影响因子: 16.6
作者: [Zhao Y, Uduman M, Siu JHY, Tull TJ, Sanderson JD, Wu YB, Zhou JQ, Petrov N, Ellis R, Todd K, Chavele KM, Guesdon W, Vossenkamper A, Jassem W, D'Cruz DP, Fear DJ, John S, Scheel-Toellner D, Hopkins C, Moreno E, Woodman NL, Ciccarelli F, Heck S, Kleinstein SH, Bemark M, Spencer J]
通讯作者: Spencer J
DOI: 10.1084/jem.20202001
发表时间: 2021-04-05
期刊: The Journal of experimental medicine
影响因子: --
作者: [Tull TJ, Pitcher MJ, Guesdon W, Siu JHY, Lebrero-Fernández C, Zhao Y, Petrov N, Heck S, Ellis R, Dhami P, Kadolsky UD, Kleeman M, Kamra Y, Fear DJ, John S, Jassem W, Groves RW, Sanderson JD, Robson MG, D'Cruz DP, Bemark M, Spencer J]
通讯作者: Spencer J
Human intestinal lymphoid tissue in time and space.
时间和空间上的人体肠道淋巴组织。
DOI: 10.1038/s41385-018-0120-6
发表时间: 2019
期刊: Mucosal immunology
影响因子: 8
作者: [Spencer J]
通讯作者: Spencer J
Checkpoint governing B cell fate decisions in human gut-associated lymphoid tissue.
  • 批准号:
    MR/L009382/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $48.11万
  • 财政年份:
    2014
  • 负责人:
    Jo Spencer
  • 依托单位:
Generation of human intestinal IgA plasma cells: roles of innate and adaptive immunity.
  • 批准号:
    BB/E000371/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $44.15万
  • 财政年份:
    2007
  • 负责人:
    Jo Spencer
  • 依托单位:
国内基金
海外基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    顾媛
  • 依托单位:
T-cell Receptor信号通路调控基因的表达机制分子解析
  • 批准号:
    32570839
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2025
  • 负责人:
    范高峰
  • 依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王锐智
  • 依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位: